Hennion & Walsh Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,975
Closed -$1.21M 879
2024
Q3
$1.21M Sell
2,975
-1,882
-39% -$689K 0.06% 406
2024
Q2
$1.56M Sell
4,857
-1,908
-28% -$620K 0.08% 314
2024
Q1
$2.26M Sell
6,765
-3,061
-31% -$935K 0.12% 231
2023
Q4
$2.66M Sell
9,826
-113
-1% -$27.9K 0.15% 195
2023
Q3
$2.44M Buy
9,939
+3,226
+48% +$883K 0.16% 178
2023
Q2
$2.04M Buy
6,713
+1,981
+42% +$551K 0.12% 210
2023
Q1
$1.25M Buy
4,732
+2,125
+82% +$540K 0.08% 313
2022
Q4
$626K Buy
+2,607
New +$584K 0.04% 451

Other funds holding HCA

Hennion & Walsh Asset Management's HCA Position: Q4 2024 in Review

Hennion & Walsh Asset Management sold out of HCA Healthcare (HCA) in Q4 2024, closing a stake of 2,975 shares — an estimated $1.21M sold.

Hennion & Walsh Asset Management first reported a position in HCA in Q4 2022 and held it in 8 quarters. The position peaked at $2.66M in Q4 2023. 1,180 funds tracked by Wall St. Rank hold HCA as of Q4 2024.

  • Hennion & Walsh Asset Management reported no remaining HCA Healthcare position as of Q4 2024 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 2,975 HCA Healthcare shares in Q4 2024, an estimated $1.21M.
  • Hennion & Walsh Asset Management first reported a position in HCA Healthcare in Q4 2022 and held it in 8 quarters.
  • Hennion & Walsh Asset Management's HCA Healthcare position peaked at $2.66M in Q4 2023.
  • 1,180 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2024.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2024, filed 15 Jan 2025.